News and Updates
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Number of submitted proposals - HORIZON-MISS-2024-NEB-01
Call HORIZON-MISS-2024-NEB-01 has closed on 19 September 2024.
93 proposals have been submitted.
The breakdown per call topic is:
HORIZON-MISS-2024-NEB-01 (RIA): 29 proposals
HORIZON-MISS-2024-NEB-02 (IA): 58 proposals
HORIZON-MISS-2024-NEB-03 (CSA): 6 proposals
Evaluation results are expected to be communicated by January 2025.
Source: Funding and Tenders Portal
Related News
|
2024-12-10
|
1 week ago |
STARHAUS Open Calls on Open Innovation and Creativity |
|
2024-12-09
|
1 week ago |
SpongeWorks Open Call |
|
2024-11-12
|
1 month ago |
Call for technical assistance under the mission on ocean and waters now open |
|
2024-11-05
|
1 month ago |
NCP Flanders team: Reshuffle of responsibilities of our NCP Advisors - Horizon Europe... |
|
2024-10-03
|
2 months ago |
Update: Joint Call on "Water for Circular Economy" open |
|
2024-09-25
|
2 months ago |
Submitted proposals - Cancer Mission 2024 Call |
|
2024-09-20
|
3 months ago |
New calls for Mission "Climate neutral and smart cities" are now open |
|
2024-09-09
|
3 months ago |
canSERV : Open call for Transnational Services - Cascade funding |
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Latest News
1504 articles available search in articlesHorizon Europe Digital Europe Defence
Happy holidays!
The NCP Flanders team wishes you happy holidays and all the best for 2025! Please note that our offices are closed between Christmas and new year. read more
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
